These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34418636)

  • 81. Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb
    Singh YP; Chhabra SC; Lashkari K; Taneja A; Garg A; Chandra A; Chhabra M; Singh GP; Jain S
    Int J Artif Organs; 2020 Jun; 43(6):372-378. PubMed ID: 31868078
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cytokine adsorption and ECMO in patients with COVID-19 - Author's reply.
    Supady A
    Lancet Respir Med; 2021 Aug; 9(8):e72-e74. PubMed ID: 34242580
    [No Abstract]   [Full Text] [Related]  

  • 83. Interhospital transport of COVID-19 patients on ECMO and comparison with historic controls.
    Blanco-Schweizer P; Sánchez-Ballesteros J; Herrán-Monge R; Prieto-deLamo A; de Ayala-Fernández JA; García-García M
    Med Intensiva (Engl Ed); 2021 Dec; 45(9):e65-e67. PubMed ID: 34839888
    [No Abstract]   [Full Text] [Related]  

  • 84. Hemoperfusion and blood purification strategies in patients with COVID-19: A systematic review.
    Sanfilippo F; Martucci G; La Via L; Cuttone G; Dimarco G; Pulizzi C; Arcadipane A; Astuto M
    Artif Organs; 2021 Dec; 45(12):1466-1476. PubMed ID: 34632596
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Long-Term Outcomes Are Important: Extracorporeal Membrane Oxygenation for COVID-19.
    Ortoleva J; Dalia AA
    J Cardiothorac Vasc Anesth; 2021 Jul; 35(7):2007-2008. PubMed ID: 33744109
    [No Abstract]   [Full Text] [Related]  

  • 86. Does adjunctive hemoadsorption provide benefit in the management of ischemia-reperfusion syndrome following near-drowning? A case report.
    Kovacevic P; Dragic S; Jandric M; Momcicevic D; Malesevic V; Kovacevic T; Matejic-Spasic M; Knezevic T; Zlojutro B
    Front Med (Lausanne); 2024; 11():1341156. PubMed ID: 38633302
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial.
    Kanjo A; Molnar Z; Zádori N; Gede N; Erőss B; Szakó L; Kiss T; Márton Z; Malbrain MLNG; Szuldrzynski K; Szrama J; Kusza K; Kogelmann K; Hegyi P
    BMJ Open; 2021 Aug; 11(8):e050464. PubMed ID: 34446497
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial.
    Meiser A; Volk T; Wallenborn J; Guenther U; Becher T; Bracht H; Schwarzkopf K; Knafelj R; Faltlhauser A; Thal SC; Soukup J; Kellner P; Drüner M; Vogelsang H; Bellgardt M; Sackey P;
    Lancet Respir Med; 2021 Nov; 9(11):1231-1240. PubMed ID: 34454654
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hemoadsorption Treatment with CytoSorb® in Probable Hemophagocytic Lymphohistiocytosis: A Role as Adjunctive Therapy?
    Ceruti S; Glotta A; Adamson H; Mauri R; Molnar Z
    Case Rep Hematol; 2021; 2021():5539126. PubMed ID: 34462671
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Immunometabolic signatures predict risk of progression to sepsis in COVID-19.
    Herrera-Van Oostdam AS; Castañeda-Delgado JE; Oropeza-Valdez JJ; Borrego JC; Monárrez-Espino J; Zheng J; Mandal R; Zhang L; Soto-Guzmán E; Fernández-Ruiz JC; Ochoa-González F; Trejo Medinilla FM; López JA; Wishart DS; Enciso-Moreno JA; López-Hernández Y
    PLoS One; 2021; 16(8):e0256784. PubMed ID: 34460840
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Elements of Th1/Th2 response and disease severity in COVID-19 patients: A short report.
    Akinosoglou K; Delastic AL; Dimakopoulou V; Marangos M; Gogos C
    J Med Virol; 2022 Jan; 94(1):404-406. PubMed ID: 34460125
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Continuous renal replacement therapy under special conditions like sepsis, burn, cardiac failure, neurotrauma, and liver failure.
    Davenport A; Honore PM
    Semin Dial; 2021 Nov; 34(6):457-471. PubMed ID: 34448261
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
    Tenforde MW; Self WH; Naioti EA; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; Gaglani M; McNeal T; Ghamande S; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Stephenson M; Schrag SJ; Kobayashi M; Verani JR; Patel MM; ;
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1156-1162. PubMed ID: 34437524
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19.
    Bayraktar N; Turan H; Bayraktar M; Ozturk A; Erdoğdu H
    J Med Virol; 2022 Jan; 94(1):154-160. PubMed ID: 34427934
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Undetected and Relatively Sustained Severe Acute Respiratory Syndrome Coronavirus 2 Circulation Worldwide During 2019.
    Petti S
    Clin Infect Dis; 2022 Apr; 74(7):1313-1314. PubMed ID: 34420046
    [No Abstract]   [Full Text] [Related]  

  • 96. Severe Patients With ARDS With COVID-19 Treated With Extracorporeal Membrane Oxygenation in China: A Retrospective Study.
    Lai W; Li S; Du Z; Ma X; Lu J; Gao WD; Abbott GW; Hu Z; Kang Y
    Front Med (Lausanne); 2021; 8():699227. PubMed ID: 34746170
    [No Abstract]   [Full Text] [Related]  

  • 97. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response.
    Supady A; Duerschmied D
    J Crit Care; 2021 Dec; 66():31-32. PubMed ID: 34418636
    [No Abstract]   [Full Text] [Related]  

  • 98. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement.
    Köhler T; Schwier E; Henzler D; Eickmeyer C
    J Crit Care; 2021 Dec; 66():187-188. PubMed ID: 34330558
    [No Abstract]   [Full Text] [Related]  

  • 99. Reply: Does adjunctive hemoadsorption with CytoSorb® affect survival of COVID-19 patients on ECMO? A critical statement.
    Putzu A; Schorer R
    J Crit Care; 2021 Dec; 66():189-190. PubMed ID: 34334278
    [No Abstract]   [Full Text] [Related]  

  • 100. Hemoadsorption in critically ill patients with or without COVID-19: A word of caution.
    Putzu A; Schorer R
    J Crit Care; 2021 Oct; 65():140-141. PubMed ID: 34148009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.